|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000180104 |
Summary for EXOC3 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000180104 | Gene symbol | EXOC3 |
| Gene name | exocyst complex component 3 | |
| HGNC | 30378 | |
| Entrez ID | 11336 | |
| Gene type | protein_coding | |
| Synonyms | EXOC3|Sec6p | |
| UniProtAcc | O60645 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for EXOC3 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for EXOC3 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for EXOC3 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUAD | cg17553881 | chr5:443872 | CGI:chr5:442705-443489 | promoter,gene body | 2.19e-01 | 3.27e-01 | -3.44e+00 | 5.72e-04 | 1.21e-03 | -1.08e-01 |
| LUAD | cg16322479 | chr5:444113 | CGI:chr5:442705-443489 | promoter,gene body | 6.36e-01 | 7.62e-01 | -3.38e+00 | 7.15e-04 | 1.46e-03 | -1.26e-01 |
| LUSC | cg17553881 | chr5:443872 | CGI:chr5:442705-443489 | promoter,gene body | 1.95e-01 | 3.17e-01 | -2.80e+00 | 5.07e-03 | 8.24e-03 | -1.23e-01 |
| LUSC | cg21151960 | chr5:443965 | CGI:chr5:442705-443489 | promoter,gene body | 4.52e-01 | 6.86e-01 | -4.00e+00 | 6.36e-05 | 5.92e-04 | -2.35e-01 |
| LUSC | cg16322479 | chr5:444113 | CGI:chr5:442705-443489 | promoter,gene body | 4.90e-01 | 7.67e-01 | -4.22e+00 | 2.44e-05 | 5.26e-04 | -2.77e-01 |
| CHOL | cg21151960 | chr5:443965 | CGI:chr5:442705-443489 | promoter,gene body | 4.49e-01 | 6.40e-01 | -2.51e+00 | 1.22e-02 | 2.39e-02 | -1.91e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg21151960 | chr5:443965 | CGI:chr5:442705-443489 | promoter,gene body | 4.61e-01 | 5.87e-01 | -8.14e+00 | 4.09e-16 | 1.63e-15 | -1.26e-01 |
| HNSC | cg21151960 | chr5:443965 | CGI:chr5:442705-443489 | promoter,gene body | 5.58e-01 | 6.64e-01 | -2.12e+00 | 3.44e-02 | 3.88e-02 | -1.06e-01 |
| HNSC | cg16322479 | chr5:444113 | CGI:chr5:442705-443489 | promoter,gene body | 5.79e-01 | 6.86e-01 | -2.14e+00 | 3.25e-02 | 3.74e-02 | -1.06e-01 |
| LIHC | cg17553881 | chr5:443872 | CGI:chr5:442705-443489 | promoter,gene body | 1.75e-01 | 3.17e-01 | -4.44e+00 | 9.20e-06 | 6.46e-05 | -1.42e-01 |
| LIHC | cg16322479 | chr5:444113 | CGI:chr5:442705-443489 | promoter,gene body | 6.40e-01 | 7.92e-01 | -3.38e+00 | 7.38e-04 | 1.78e-03 | -1.52e-01 |
Top |
Exon skipping events with PSI in TCGA for EXOC3 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for EXOC3 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for EXOC3 |
| TFs related to EXOC3. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | PLAGL2 | EXOC3 | 3.21e+00 | 5.95e-03 | 4.58e+00 | 9.85e-01 | Female-biased |
| EXOC3 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for EXOC3 |
| RBPs related to ES in EXOC3. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| STAD | SAMD4A | exon_skip_433639 | 8.88e+00 | 9.94e-01 | 8.23e+00 | 1.03e-03 | Male-biased |
| UVM | SAMD4A | exon_skip_433639 | 8.32e+00 | 9.89e-01 | 7.94e+00 | 3.33e-03 | Male-biased |
| LIHC | SAMD4A | exon_skip_433639 | 8.62e+00 | 9.88e-01 | 8.16e+00 | 5.60e-03 | Male-biased |
| LUSC | HNRNPA1L2 | exon_skip_433660 | 8.70e+00 | 5.14e-03 | 9.12e+00 | 9.91e-01 | Female-biased |
| LUSC | SAMD4A | exon_skip_433639 | 8.80e+00 | 9.87e-01 | 8.40e+00 | 7.71e-03 | Male-biased |
| DLBC | HNRNPA1L2 | exon_skip_433660 | 8.72e+00 | 1.28e-02 | 9.03e+00 | 9.83e-01 | Female-biased |
| CHOL | HNRNPA1L2 | exon_skip_433660 | 9.07e+00 | 7.14e-03 | 9.52e+00 | 9.90e-01 | Female-biased |
| CHOL | STAR-PAP | exon_skip_433635 | 1.20e+01 | 9.87e-01 | 1.16e+01 | 1.27e-02 | Male-biased |
| BRCA | HNRNPA1L2 | exon_skip_433660 | 9.22e+00 | 9.88e-01 | 8.61e+00 | 7.96e-03 | Male-biased |
| BRCA | SAMD4A | exon_skip_433639 | 8.39e+00 | 1.60e-03 | 9.62e+00 | 9.96e-01 | Female-biased |
| THCA | NCL | exon_skip_433654 | 7.03e+00 | 9.80e-01 | 6.70e+00 | 6.18e-03 | Male-biased |
| PCPG | HNRNPA1L2 | exon_skip_433660 | 8.88e+00 | 8.11e-04 | 9.42e+00 | 9.96e-01 | Female-biased |
| MESO | HNRNPA1L2 | exon_skip_433660 | 8.94e+00 | 3.73e-03 | 9.38e+00 | 9.93e-01 | Female-biased |
| MESO | STAR-PAP | exon_skip_433635 | 1.16e+01 | 3.22e-03 | 1.21e+01 | 9.96e-01 | Female-biased |
| PAAD | STAR-PAP | exon_skip_433635 | 1.19e+01 | 3.95e-04 | 1.24e+01 | 9.99e-01 | Female-biased |
| KIRC | HNRNPA1L2 | exon_skip_433660 | 9.01e+00 | 9.87e-01 | 8.69e+00 | 9.31e-03 | Male-biased |
| KICH | HNRNPA1L2 | exon_skip_433660 | 8.83e+00 | 2.64e-03 | 9.27e+00 | 9.94e-01 | Female-biased |
| KICH | SAMD4A | exon_skip_433639 | 7.99e+00 | 7.88e-03 | 8.33e+00 | 9.85e-01 | Female-biased |
| KICH | STAR-PAP | exon_skip_433635 | 1.16e+01 | 1.95e-03 | 1.20e+01 | 9.97e-01 | Female-biased |
| EXOC3 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs10069126 | chr5:4157392:C:G | - | 0.29686838325948 | 0.0122859746942743 | PAAD | Female-baised eQTL |
| rs11750185 | chr5:9674624:T:C | - | 0.104361118161644 | 0.0183835694005293 | HNSC | Female-baised eQTL |
| rs2074608 | chr5:9196783:G:C | - | 0.164979640586913 | 0.011558029955387 | BLCA | Female-baised eQTL |
| rs6555595 | chr5:9198860:T:C | - | 0.164269911471563 | 0.0126043143998513 | BLCA | Female-baised eQTL |
| rs3822776 | chr5:9197730:G:T | - | 0.167611934459031 | 0.0127884449967212 | BLCA | Female-baised eQTL |
| rs73740392 | chr5:9197786:T:G | - | 0.162354950660481 | 0.0176238038088564 | BLCA | Female-baised eQTL |
| rs73740393 | chr5:9197788:T:G | - | 0.162354950660481 | 0.0176238038088564 | BLCA | Female-baised eQTL |
| rs7731357 | chr5:5328568:C:T | - | 0.0607079965952012 | 0.0205106967041787 | LUAD | Female-baised eQTL |
| rs10053085 | chr5:6841894:G:A | - | -0.0436189280357226 | 0.0223310444702023 | LUAD | Female-baised eQTL |
| rs903083 | chr5:4092096:T:C | - | -0.0539806450557368 | 0.0228894577156596 | LUAD | Female-baised eQTL |
| rs870348 | chr5:6844904:A:T | - | -0.043635372702912 | 0.0275299084380664 | LUAD | Female-baised eQTL |
| rs13356203 | chr5:6849242:G:A | - | -0.0421521813333433 | 0.0414558526254101 | LUAD | Female-baised eQTL |
| rs74755975 | chr5:3422618:G:A | - | 0.106562769219088 | 0.0446823159547744 | COAD | Female-baised eQTL |
| rs112468583 | chr5:3425530:T:C | - | 0.106562769219088 | 0.0446823159547744 | COAD | Female-baised eQTL |
| rs78000638 | chr5:3430081:C:T | - | 0.106562769219088 | 0.0446823159547744 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs10155613 | chr5:2055214:T:C | - | 0.12000308081159 | 0.00836161835037151 | THCA | Male-baised eQTL |
| rs16883737 | chr5:9851109:G:C | - | 0.0975573495202054 | 0.0406804308898695 | STAD | Male-baised eQTL |
| rs16883740 | chr5:9851222:T:C | - | 0.0975573495202054 | 0.0406804308898695 | STAD | Male-baised eQTL |
| rs905843 | chr5:6528747:G:A | - | 0.0607474602019309 | 4.00160155959687e-05 | BLCA | Male-baised eQTL |
| rs34088226 | chr5:4308833:G:A | - | 0.0506793408413206 | 0.017194559519341 | BLCA | Male-baised eQTL |
| rs4702639 | chr5:9716191:C:T | - | 0.0458466854199467 | 0.0193758830438176 | BLCA | Male-baised eQTL |
| rs4701848 | chr5:9715684:A:G | - | 0.0457743323260491 | 0.0197474139035143 | BLCA | Male-baised eQTL |
| rs16880898 | chr5:8627414:A:T | - | 0.0329665518416504 | 0.0434295682862771 | BLCA | Male-baised eQTL |
| rs10062600 | chr5:9729704:G:T | - | 0.0436507746580835 | 0.00418801281106249 | LUAD | Male-baised eQTL |
| rs16883461 | chr5:9730260:A:C | - | 0.0398698407414078 | 0.00892076696600282 | LUAD | Male-baised eQTL |
| rs12655182 | chr5:5228206:G:T | - | 0.0918144603389479 | 0.0182397117094367 | LUAD | Male-baised eQTL |
| rs10062592 | chr5:9729674:G:A | - | 0.0405714657773775 | 0.0288708547694334 | LUAD | Male-baised eQTL |
| rs29675 | chr5:163654:G:A | - | -0.0379771158886153 | 0.030175597658012 | LUAD | Male-baised eQTL |
| rs2202445 | chr5:7328063:G:C | - | 0.0350550407427147 | 0.0364241826139235 | LUAD | Male-baised eQTL |
| rs73037129 | chr5:5228802:G:A | - | 0.0636502531829807 | 0.0408738322018969 | LUAD | Male-baised eQTL |
| rs67061933 | chr5:7317848:A:G | - | 0.0350809144630354 | 0.0418888817532674 | LUAD | Male-baised eQTL |
| rs11750162 | chr5:7316843:A:G | - | 0.034637940223018 | 0.0433464257404281 | LUAD | Male-baised eQTL |
| rs56173220 | chr5:8271488:A:G | - | 0.0397423345012485 | 0.0450447319382478 | LUAD | Male-baised eQTL |
| rs1876158 | chr5:8271542:T:C | - | 0.0397423345012485 | 0.0450447319382478 | LUAD | Male-baised eQTL |
| rs10053047 | chr5:7318478:C:T | - | 0.0352404382549352 | 0.0452756569659451 | LUAD | Male-baised eQTL |
| rs80311093 | chr5:2532445:A:G | - | 0.0720855474638988 | 0.0111248733916818 | COAD | Male-baised eQTL |
| rs34353738 | chr5:2533012:A:G | - | 0.0720855474638988 | 0.0111248733916818 | COAD | Male-baised eQTL |
| rs6893457 | chr5:2533215:G:C | - | 0.0720855474638988 | 0.0111248733916818 | COAD | Male-baised eQTL |
| rs34072096 | chr5:2534021:G:A | - | 0.0720855474638988 | 0.0111248733916818 | COAD | Male-baised eQTL |
| rs11744632 | chr5:2534260:C:T | - | 0.0720855474638988 | 0.0111248733916818 | COAD | Male-baised eQTL |
| rs6555425 | chr5:7021848:C:G | - | -0.0573880745429349 | 0.0116436212768929 | COAD | Male-baised eQTL |
| rs72720952 | chr5:2535603:G:A | - | 0.0713282980088842 | 0.0122031416102573 | COAD | Male-baised eQTL |
| rs17657162 | chr5:2535680:A:G | - | 0.0713282980088842 | 0.0122031416102573 | COAD | Male-baised eQTL |
| rs16869904 | chr5:2536677:C:A | - | 0.0709224701090468 | 0.0158762653152075 | COAD | Male-baised eQTL |
| rs1864071 | chr5:7436799:T:C | - | -0.0635691148402595 | 0.0173525330851052 | COAD | Male-baised eQTL |
| rs6886502 | chr5:2537549:G:C | - | 0.0699780171994976 | 0.0182217997268544 | COAD | Male-baised eQTL |
| rs6887706 | chr5:2537567:C:T | - | 0.0699780171994976 | 0.0182217997268544 | COAD | Male-baised eQTL |
| rs6888076 | chr5:2537780:C:T | - | 0.0699780171994976 | 0.0182217997268544 | COAD | Male-baised eQTL |
| rs6895153 | chr5:2533472:C:T | - | 0.069192837515017 | 0.0183999440128728 | COAD | Male-baised eQTL |
| rs74726970 | chr5:3158891:C:T | - | -0.0779085749101503 | 0.0195755912375714 | COAD | Male-baised eQTL |
| rs72720951 | chr5:2532366:A:G | - | 0.0691902993620015 | 0.0205249484152421 | COAD | Male-baised eQTL |
| rs275479 | chr5:6833683:A:G | - | 0.0561917526130913 | 0.0207541041611417 | COAD | Male-baised eQTL |
| rs11748863 | chr5:3485286:T:A | - | -0.068413582020167 | 0.0246481884832561 | COAD | Male-baised eQTL |
| rs4866570 | chr5:3485873:G:T | - | -0.0686845673659398 | 0.0277039849022846 | COAD | Male-baised eQTL |
| rs17598228 | chr5:2530680:G:A | - | 0.0648128539415763 | 0.0293152213662052 | COAD | Male-baised eQTL |
| rs13164496 | chr5:2529768:G:A | - | 0.065828704737685 | 0.0294425441955051 | COAD | Male-baised eQTL |
| rs72720948 | chr5:2530408:C:T | - | 0.065828704737685 | 0.0294425441955051 | COAD | Male-baised eQTL |
| rs4701737 | chr5:6552711:G:T | - | -0.0528182425789984 | 0.0306135553991698 | COAD | Male-baised eQTL |
| rs17622945 | chr5:3134669:C:T | - | -0.0918409781960121 | 0.0307220910077146 | COAD | Male-baised eQTL |
| rs34235556 | chr5:2528537:T:A | - | 0.0651620999744329 | 0.0327456780066382 | COAD | Male-baised eQTL |
| rs36004048 | chr5:2528569:C:T | - | 0.0651620999744329 | 0.0327456780066382 | COAD | Male-baised eQTL |
| rs1394652 | chr5:8789831:C:T | - | -0.0511317751217436 | 0.0343014181481189 | COAD | Male-baised eQTL |
| rs13171426 | chr5:2525770:G:A | - | 0.0644660486922399 | 0.0364866445533227 | COAD | Male-baised eQTL |
| rs71577537 | chr5:2526629:C:T | - | 0.0644660486922399 | 0.0364866445533227 | COAD | Male-baised eQTL |
| rs35234285 | chr5:2527407:A:G | - | 0.0644660486922399 | 0.0364866445533227 | COAD | Male-baised eQTL |
| rs13174380 | chr5:2527752:A:G | - | 0.0644660486922399 | 0.0364866445533227 | COAD | Male-baised eQTL |
| rs3925077 | chr5:9915287:G:A | - | 0.0657963543286806 | 0.0410302725525193 | COAD | Male-baised eQTL |
| rs80168598 | chr5:3142331:G:C | - | -0.090975060581246 | 0.0419068779090766 | COAD | Male-baised eQTL |
| rs79643392 | chr5:3142732:C:G | - | -0.090975060581246 | 0.0419068779090766 | COAD | Male-baised eQTL |
| rs78362215 | chr5:3145121:C:T | - | -0.090975060581246 | 0.0419068779090766 | COAD | Male-baised eQTL |
| rs80169374 | chr5:3148926:C:T | - | -0.090975060581246 | 0.0419068779090766 | COAD | Male-baised eQTL |
| rs146723777 | chr5:3141242:C:T | - | -0.09034387764815 | 0.0442666004591529 | COAD | Male-baised eQTL |
| rs181812432 | chr5:3141267:C:T | - | -0.09034387764815 | 0.0442666004591529 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000180104 |
| CpG Site: cg21151960 | |
| Position to Gene: gene,promoter | |
| Male Effect: - | |
| Female Effect: -0.299376120235621 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg21151960 | chr5:443965 | gene,promoter | -0.299376120235621 | 8.25899327948447e-09 | -0.4041527122062985 | 1.9389468772237625e-11 | LUAD |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of EXOC3 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
